Switzerland's AEVIS VICTORIA Q1 net revenue rises 1.5%, profitability improves

Aevis Victoria SA

06/05/2026 06:24

Overview

Switzerland healthcare investor's Q1 net revenue rose 1.5% yr/yr

EBITDAR and EBITDA margins improved on restructuring and cost controls

Headline revenue growth distorted by tariff changes; net revenue seen as more relevant

Outlook

Company enters remainder of 2026 with confidence, maintaining strict cost discipline

Company will focus on operational optimization, facility integration, and outpatient care development

Company closely monitoring developments in the tariff framework

Result Drivers

RESTRUCTURING AND COST CONTROL - Co said improved profitability was driven by restructuring measures begun in 2025, which enabled better cost control and operational efficiency

TARIFF AGREEMENT CHANGES - Apparent revenue growth mainly reflected changes in presentation due to new tariff agreements with insurers, distorting year-on-year comparisons

Company press release: ID:nEQ7xHgRLa

Key Details

Metric
Beat/Miss
Actual
Consensus Estimate
Q1 Net Revenue
CHF 226 mln


Analyst Coverage

The one available analyst rating on the shares is "strong buy"

The average consensus recommendation for the healthcare facilities & services peer group is "buy."

Wall Street's median 12-month price target for Aevis Victoria SA is CHF17.00, about 25.9% above its May 5 closing price of CHF13.50

The stock recently traded at 82 times the next 12-month earnings vs. a P/E of 114 three months ago

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)